Location History:
- Mumbai, IN (2013 - 2014)
- Maharashtra, IN (2014)
Company Filing History:
Years Active: 2013-2014
Title: The Innovations of Digamber Shripati Pawar
Introduction
Digamber Shripati Pawar is a notable inventor based in Mumbai, India, recognized for his contributions to the field of peptide synthesis. With a total of three patents to his name, Pawar has made significant advancements in the processes used to synthesize important peptides, including the therapeutic pramlintide.
Latest Patents
Among his latest patents, Pawar has developed a process for the synthesis of a 37-mer peptide known as pramlintide. This innovative method provides a high yield of the peptide in a relatively pure form, which can further be purified using preparative HPLC. Additionally, he has patented an improved process for the large-scale synthesis of cyclic heptapeptide. This technique utilizes the Fmoc solid phase synthesis method, coupling amino acids on a solid support resin. The process incorporates a unique combination of solvents to reduce cysteine racemization, while also employing C1-C4 alcohols as a substitute for organic nitriles to enhance efficiency and environmental safety.
Career Highlights
Pawar is currently employed at USV Private Limited, a company known for its focus on pharmaceuticals and biotechnology. His work continues to bridge the gap between research and practical applications, showcasing his expertise in peptide synthesis and its potential benefits in medical treatments.
Collaborations
Throughout his career, Pawar has collaborated with a range of professionals, including his coworkers Nikhil Umesh Mohe and Chandrakesan Muralidharan. These collaborations illustrate the importance of teamwork in advancing innovative processes within the field of pharmaceutical research.
Conclusion
Digamber Shripati Pawar stands out as an influential inventor in the innovative landscape of peptide synthesis. With his groundbreaking patents and collaborations, he is shaping the future of peptide development, contributing to advancements in medical treatments that can improve patient outcomes. His commitment to creating efficient and eco-friendly processes underscores the potential of innovation in the pharmaceutical industry.